Physician

Courtney D Ackerman, M.D.

According to 2025 Medicare claims, Courtney Ackerman, M.D. (NPI: 1790919744) practices hematology/oncology in the Frederick-Gaithersburg-Bethesda, MD market, with the plurality of this provider's patient population coming from Montgomery, MD. This provider's primary affiliated billing organization is MARYLAND ONCOLOGY HEMATOLOGY, P.A. (NPI: 1821271032; TIN: 113652573) and primary practice location at 20904-7917.

Ackerman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 719 traditional Medicare patients, billed 209,620 HCPCS/CPT codes, and received $2,789,578 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 953 prescription claims across 200 beneficiaries totaling $2,932,315 in drug costs, led by Imbruvica (Ibrutinib). DME data shows 12 claims. Open Payments data shows 154 records totaling $82,547. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $86,440 to $2,789,578. Similarly, Part D prescription costs have risen steadily, from $43,419 to $2,932,315. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $882 to $151,773.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.8M2015 Medicare payment: $86,440 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $266,308 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $750,196 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,044,659 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,510,681 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,413,958 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,771,562 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,457,170 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,904,774 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,789,578 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151516,112$86,440
201625625,579$266,308
201743482,391$750,196
2018423168,674$2,044,659
2019443128,145$1,510,681
2020466132,035$1,413,958
2021587187,803$1,771,562
2022559219,747$2,457,170
2023644220,086$1,904,774
2024719209,620$2,789,578

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.5M$2.9M2015 Drug cost: $43,419 (USD; Tot_Drug_Cst)2016 Drug cost: $80,212 (USD; Tot_Drug_Cst)2017 Drug cost: $186,094 (USD; Tot_Drug_Cst)2018 Drug cost: $795,333 (USD; Tot_Drug_Cst)2019 Drug cost: $352,573 (USD; Tot_Drug_Cst)2020 Drug cost: $612,621 (USD; Tot_Drug_Cst)2021 Drug cost: $959,600 (USD; Tot_Drug_Cst)2022 Drug cost: $1,324,619 (USD; Tot_Drug_Cst)2023 Drug cost: $1,439,246 (USD; Tot_Drug_Cst)2024 Drug cost: $2,932,315 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152984$43,419
20162648$80,212
201741172$186,094
201872352$795,333
201966288$352,573
202074489$612,621
2021112521$959,600
2022120593$1,324,619
2023124592$1,439,246
2024200953$2,932,315

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$74K$147K2020 Medicare payment: $797 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $143,843 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $147,395 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R22$797
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R12$143,843
2024N/R12$147,395

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more358751$76
96372Injection of drug or substance under skin or into muscle205438$11
80053Blood test, comprehensive group of blood chemicals3841,276$10
36415Insertion of needle into vein for collection of blood sample125176$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count3891,335$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ImbruvicaIbrutinib23644$401,912
XtandiEnzalutamide30900$392,519
TagrissoOsimertinib Mesylate19570$303,211
VerzenioAbemaciclib18504$265,158
IbrancePalbociclib15420$240,455

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E0766Electrical stimulation device used for cancer treatment, includes all accessories, any typeYN/R12$147,395

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.150$4,292Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.4$78,254AstraZeneca Pharmaceuticals LP
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Courtney D. Ackerman, M.D.?

Tedicare shows public-source Medicare data for Courtney D. Ackerman, M.D. (NPI 1790919744), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Courtney D. Ackerman, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Courtney D. Ackerman, M.D.?

Courtney D. Ackerman, M.D. is linked to MARYLAND ONCOLOGY HEMATOLOGY, P.A. (billing NPI 1821271032) in the available physician profile data.

Does Courtney D. Ackerman, M.D. have Open Payments data?

Courtney D. Ackerman, M.D. has 154 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.